October 2, 2020 Comments Off on New patent expiration for Boehringer Ingelheim drug OFEV Posted in: Uncategorized
Annual Drug Patent Expirations for OFEV Ofev is a drug marketed by Boehringer Ingelheim and is included in one NDA. It is available from one supplier. There are five patents…
The post New patent expiration for Boehringer Ingelheim drug OFEV appeared fi…
September 28, 2020 Comments Off on New patent expiration for Novartis drug TYKERB Posted in: Uncategorized
Annual Drug Patent Expirations for TYKERB Tykerb is a drug marketed by Novartis and is included in one NDA. It is available from one supplier. There are three patents protecting…
The post New patent expiration for Novartis drug TYKERB appeared first on…